YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response

Andriana Lebid, Liam Chung, Drew M. Pardoll, Fan Pan

Research output: Contribution to journalArticlepeer-review


YAP is a transcriptional coactivator of the Hippo signaling pathway that has largely been studied for its role in the regulation of organ size during development. Several studies have shown that YAP is upregulated in cancer cells, and more recently in the T regulatory (Treg) subset of CD4+ cells. These observations suggest that the transcriptional co-activator may promote tumor persistence and progression. Here, we report that YAP also plays an immunoinhibitory role in CD8 T cells, especially in activated cytotoxic cells usually found in the tumor microenvironment. Our findings add further rationale for the development and use of pharmacologic inhibitors of YAP to treat cancer.

Original languageEnglish (US)
Article number580
JournalFrontiers in immunology
StatePublished - Apr 8 2020


  • CD8 T cell
  • YAP
  • hippo
  • immunesuppression
  • tumor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response'. Together they form a unique fingerprint.

Cite this